Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...

Indianapolis-based pharmaceutical giant Eli Lilly confirms plans to build a $5 billion manufacturing facility just west of Richmond, Virginia. (Courtesy Eli Lilly) Indianapolis-based pharmaceutical ...

Patients on Eli Lilly & Co.’s experimental diabetes pill lost more weight and had better blood sugar control than those on an older, approved rival from Novo Nordisk A/S in the first head-to-head ...

Eli Lilly on Tuesday announced a $5 billion investment in a manufacturing facility in Virginia as the pharmaceutical giant looks to expand its domestic production capacity amid the threat of tariffs.

Eli Lilly & Co.’s obesity pill prompted enough weight loss in a large clinical trial to be meaningful for patients and have far-reaching implications for the field, doctors said. The US drugmaker’s ...

Eli Lilly is making waves in the corporate debt market with a $6.75 billion multi-tranche bond sale that includes a rare 40-year note: an unusual move for a pharmaceutical company. Most corporate ...

Sept. 16 (UPI) --Medical company Eli Lilly said Tuesday around $5 billon will be go toward construction of its new facility in Virginia just west of Richmond. The Indiana-based Eli Lilly said its new ...

Eli Lilly and Co. on Tuesday officially announced plans to build a $5 billion manufacturing plant just west of Richmond, Virginia, part of the Indianapolis drugmaker’s commitment to add U.S.

A federal appeals court on Thursday rejected Eli Lilly’s appeal of an $183.7 million judgment won by a whistleblowing lawyer and pharmacist who accused the drugmaker of defrauding Medicaid. The 7th ...

Sept 9 (Reuters) - Drugmaker Eli Lilly (LLY.N), opens new tab said on Tuesday it is launching an artificial intelligence and machine learning platform that provides biotech companies access to drug ...

(RTTNews) - Eli Lilly and Company (LLY) Tuesday said it has launched TuneLab, an artificial intelligence and machine learning (AI/ML) platform to provide biotechnology companies access to drug ...

Eli Lilly and Co. (NYSE:LLY) on Tuesday launched Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that provides biotech companies access to drug discovery models trained ...